Diagnostic Challenge and Therapeutic Dilemma in Necrotizing Myopathy
Authors
Affiliations
Munekane A, Ohsawa Y, Okubo M, Nagai T, Nishimura H, Nishino I Intern Med. 2022; 62(9):1345-1349.
PMID: 36130887 PMC: 10208778. DOI: 10.2169/internalmedicine.0202-22.
Tanboon J, Uruha A, Arahata Y, Dittmayer C, Schweizer L, Goebel H Brain Pathol. 2021; 31(3):e12962.
PMID: 34043258 PMC: 8412091. DOI: 10.1111/bpa.12962.
Tiniakou E, Pinal-Fernandez I, Lloyd T, Albayda J, Paik J, Werner J Rheumatology (Oxford). 2017; 56(5):787-794.
PMID: 28096458 PMC: 5850825. DOI: 10.1093/rheumatology/kew470.
Immune-mediated necrotizing myopathy.
Bergua C, Chiavelli H, Simon J, Boyer O, Jouen F, Stenzel W Z Rheumatol. 2016; 75(2):151-6.
PMID: 26783154 DOI: 10.1007/s00393-015-0029-3.
Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.
Mammen A, Casciola-Rosen L, Christopher-Stine L, Lloyd T, Wagner K Neurol Neuroimmunol Neuroinflamm. 2015; 2(6):e172.
PMID: 26668818 PMC: 4676353. DOI: 10.1212/NXI.0000000000000172.